InvestSMART

Cynata Therapeutics Limited (ASX: CYP) - Announcements

- Current share price for CYP : $0.013

ASX company news and announcements for Cynata Therapeutics Limited (CYP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Cynata Therapeutics Limited (CYP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Cynata Therapeutics Limited (CYP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Cynata Therapeutics Limited (CYP)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$4 Proposed issue of securities - CYP 13 Nov 2026 8:35AM $0.013 $0.013 fallen by 0%
$4 Update - Proposed issue of securities - CYP 13 Nov 2026 8:33AM $0.013 $0.013 fallen by 0%
$4 Update on Proposed Placement and Corporate Activities 13 Nov 2026 8:31AM $0.013 $0.013 fallen by 0%
$4 Change in substantial holding 5 Nov 2026 5:02PM $0.013 $0.013 fallen by 0%
$4 Proposed issue of securities - CYP 4 Nov 2026 9:09AM $0.010 $0.013 risen by 30%
$4 Commitments received for further $550k via placement 4 Nov 2026 9:08AM $0.010 $0.013 risen by 30%
$4 Appendix 3Y-Ms Janine Rolfe 3 Nov 2026 12:36PM $0.010 $0.013 risen by 30%
$4 Appendix 3Y-Dr Kilian Kelly 3 Nov 2026 12:33PM $0.010 $0.013 risen by 30%
$4 Appendix 3Y-Dr Geoffrey Brooke 3 Nov 2026 12:32PM $0.010 $0.013 risen by 30%
$4 Notification regarding unquoted securities - CYP 3 Nov 2026 10:14AM $0.011 $0.013 risen by 18.18%
$4 Notification regarding unquoted securities - CYP 3 Nov 2026 10:14AM $0.011 $0.013 risen by 18.18%
$4 Application for quotation of securities - CYP 3 Nov 2026 10:12AM $0.011 $0.013 risen by 18.18%
$4 Cleansing Notice 30 Oct 2026 3:47PM $0.012 $0.013 risen by 8.33%
$4 Application for quotation of securities - CYP 30 Oct 2026 3:44PM $0.012 $0.013 risen by 8.33%
$4 Consultancy Agreement 30 Oct 2026 10:06AM $0.011 $0.013 risen by 18.18%
$4 Results of Fully Underwritten Entitlement Offer 30 Oct 2026 8:57AM $0.012 $0.013 risen by 8.33%
$4 September 2026 Quarterly Activity Report & Appendix 4C 27 Oct 2026 9:50AM $0.011 $0.013 risen by 18.18%
$4 Letter to Shareholders, Notice of AGM & Proxy Form 23 Oct 2026 1:02PM $0.011 $0.013 risen by 18.18%
$4 Paul Wotton to Resign as Director from AGM 22 Oct 2026 12:29PM $0.011 $0.013 risen by 18.18%
$4 Unmarketable Parcel Sale Facility 20 Oct 2026 10:00AM $0.010 $0.013 risen by 30%
$4 Notification of buy-back - CYP 20 Oct 2026 9:25AM $0.010 $0.013 risen by 30%
$4 Letter to Ineligible Shareholders-Entitlement Offer 16 Oct 2026 9:26AM $0.011 $0.013 risen by 18.18%
$4 Letter to Eligible Shareholders-Entitlement Offer 16 Oct 2026 9:25AM $0.011 $0.013 risen by 18.18%
$4 Replacement Target Market Determination 12 Oct 2026 6:35PM $0.012 $0.013 risen by 8.33%
$4 Replacement Prospectus 12 Oct 2026 5:11PM $0.012 $0.013 risen by 8.33%

1 - 25 of 740 results

Page 1 of 30

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.